In this study, SHH, PTCH1, and GLI1 expression levels were found to be upregulated in IM-resistant patient samples as well as in CML variants relative to CP-CML patients and the K562 cell line [63]. Here, GLI1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.